Levamisole exacerbates coxsackievirus B3-induced murine myocarditis.

Infection and Immunity
R J GudvangenC J Gauntt


Levamisole administration to several strains of adolescent mice at the time of or up to 4 days post-inoculation (p.i.) with a myocarditic variant of coxsackievirus B3 (CVB3m) increased the number of myocarditic lesions above that found in CVB3m-inoculated mice. Virus replication in heart tissues in vivo was not affected by levamisole administration to the mice, nor was production of neutralizing antibody to CVB3m. Lymphocytes from nodes of virus-inoculated mice treated with levamisole at 2 days p.i. exhibited an increased reactivity to phytohemagglutinin on days 6 and 8 p.i., compared with respective responses by nodal T lymphocytes from CVB3m-inoculated mice. Levamisole treatment of CVB3m-inoculated mice also increased the reactivity of splenic and peripheral blood T lymphocytes to phytohemagglutinin on day 8 p.i., but not day 6 p.i., compared with the respective responses by lymphocytes from CVB3m-inoculated mice. The proportion of theta antigen-bearing lymphocytes in the total lymphocyte population in peripheral blood of CVB3m-inoculated mice was not altered by levamisole treatment. However, CVB3m-induced reduction in this subpopulation of lymphocytes in the nodes was restored to control levels by levamisole treatment. React...Continue Reading


Mar 20, 1975·The New England Journal of Medicine·F S Kantor
Feb 1, 1979·Infection and Immunity·M D TrousdaleC J Gauntt
Jan 1, 1979·Journal of Medical Virology·C J GaunttT Nealon
Jun 1, 1979·Immunopharmacology·I G OtternessH E Holden
Jan 5, 1978·The New England Journal of Medicine·P A Mackowiak
May 23, 1976·Biochemical and Biophysical Research Communications·M D TrousdaleC J Gauntt
Feb 1, 1972·The American Journal of Cardiology·G E Burch, T D Giles
Jan 1, 1973·Annual Review of Medicine·W H Abelmann
Jan 1, 1973·Advances in Immunology·E F Wheelock, S T Toy
Jan 1, 1970·Annual Review of Microbiology·A L NotkinsR J Howard
Oct 1, 1980·Proceedings of the Society for Experimental Biology and Medicine·M P GomezA M Lerner
Feb 1, 1981·Immunopharmacology·I G OtternessM L Bliven

❮ Previous
Next ❯


Oct 1, 1986·Journal of Medical Virology·E K GodenyC J Gauntt
Jun 27, 2003·Current Opinion in Cardiology·Bilal AyachPeter Liu
Jan 1, 1985·Journal of Interferon Research·C W Lutton, C J Gauntt
Jan 1, 1989·Immunologic Research·L J Wolfgram, N R Rose
Feb 1, 1985·Antimicrobial Agents and Chemotherapy·C J GaunttU O Cheriyan

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.